The Effect of Logotherapy-Based Psychoeducation Applied to Family Members of Individuals Diagnosed with Schizophrenia on Finding Meaning, Hope and Depression

February 27, 2025 updated by: aslı zeynep sipahi
The resources that will strengthen the family members who play a key role in the treatment of schizophrenia should also be activated. One of these resources that enable people to cope with the difficult events they experience is finding meaning in life. The meaning of life is a basic source of motivation for an individual to live despite everything. In this respect, meaning is a source that helps them maintain their mental balance. Another concept that is considered important in terms of protecting and strengthening the mental health of family members is hope. Hope is defined as setting a goal and taking action to achieve it, and looking for different ways when faced with difficulties. Hope gives caregivers the belief that they can cope with stressful experiences. Therefore, it is important to develop hope in family members of individuals with mental disorders. Today, different therapy methods are applied to protect and improve mental health. Recent studies have shown that logotherapy is an effective method in strengthening positive psychological factors and coping with negative emotions. Logotherapy adopts "Therapy through Meaning" as its basic method. The effectiveness of logotherapy on meaning and hope has been demonstrated in many different samples. No study has been found that focuses on meaning and hope in family members of chronic psychiatric patients. This study aims to determine the effect of a logotherapy-focused psychoeducation program on the meaning in life, hope, and depression levels in families of schizophrenia patients. The results of this study are applicable to family members of individuals diagnosed with schizophrenia. Research hypotheses: H1a: Logotherapy-based psychoeducation applied to family members of individuals diagnosed with schizophrenia will cause an increase in the members' finding and searching for meaning in life, future, positive readiness and expectation, and relationships with themselves and their surroundings subscale scores. H1b: Logotherapy-based psychoeducation applied to family members of individuals diagnosed with schizophrenia will cause a decrease in the members' depression levels.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The resources that will strengthen the family members who play a key role in the treatment of schizophrenia should also be activated. One of these resources that enable people to cope with the difficult events they experience is finding meaning in life. The meaning of life is a basic source of motivation for an individual to live despite everything. In this respect, meaning is a source that helps them maintain their mental balance. Another concept that is considered important in terms of protecting and strengthening the mental health of family members is hope. Hope is defined as setting a goal and taking action to achieve it, and looking for different ways when faced with difficulties. Hope gives caregivers the belief that they can cope with stressful experiences. Therefore, it is important to develop hope in family members of individuals with mental disorders. Today, different therapy methods are applied to protect and improve mental health. Recent studies have shown that logotherapy is an effective method in strengthening positive psychological factors and coping with negative emotions. Logotherapy adopts "Therapy through Meaning" as its basic method. The effectiveness of logotherapy on meaning and hope has been demonstrated in many different samples. No study has been found that focuses on meaning and hope in family members of chronic psychiatric patients. This study aims to determine the effect of a logotherapy-focused psychoeducation program on the meaning in life, hope, and depression levels in families of schizophrenia patients. The results of this study are applicable to family members of individuals diagnosed with schizophrenia. Research hypotheses: H1a: Logotherapy-based psychoeducation applied to family members of individuals diagnosed with schizophrenia will cause an increase in the members' finding and searching for meaning in life, future, positive readiness and expectation, and relationships with themselves and their surroundings subscale scores. H1b: Logotherapy-based psychoeducation applied to family members of individuals diagnosed with schizophrenia will cause a decrease in the members' depression levels.

Type of Research This research was planned as a mixed design study using quantitative and qualitative approaches together. The quantitative phase of the research consists of a prospective, single-blind, randomized controlled study design using a pre-test-post-test design that aims to reveal the effectiveness of Logotherapy-Based Psychoeducation. The qualitative phase of the study will be applied with a phenomenological approach to clarify the attitude changes of the participants in the experimental group during and after the Logotherapy-Focused Psychoeducation Program.

Place and Time of the Research The research is planned to be conducted at the Istanbul Başakşehir Çam and Sakura City Hospital Mental Health and Hospital between December 2022 and November 2023.

Population, Sample and Sample Characteristics of the Research The population of the research will consist of family members of individuals diagnosed with schizophrenia who are followed up at the Başakşehir Çam and Sakura City Hospital Psychiatry Outpatient Clinic, and the sample will consist of family members who meet the inclusion criteria. After the sample size is calculated, randomization will be performed and the experimental and control groups will be determined.

Data Collection Tools Personal Information Form This form, created by the researcher by scanning the relevant literature, consists of 14 questions aimed at determining the sociodemographic and disease-related characteristics of the individual diagnosed with schizophrenia and his/her family member.

The Meaning of Life Scale The meaning of life scale was developed by Steger and colleagues to determine the meaning people find in life and the meaning they seek. The adaptation study for Turkey was conducted by Akın and Taş. The meaning of life scale consists of 10 items on a 7-point Likert type. The scale consists of two subscales, namely current meaning and sought meaning. The total score on the scale varies between 7 and 70. High scores obtained from the scale indicate that the individual has a high level of meaning in life. The internal consistency reliability coefficients of the scale are .82 for the current meaning subscale and .87 for the sought meaning subscale.

Herth Hope Scale The Herth Hope Scale was developed by Dr. Herth in 1991 to determine the hope levels of individuals and was adapted to Turkish by Aslan and colleagues. The scale is a four-point Likert type and consists of 30 items. The scale consists of the sub-dimensions "Future", "Positive readiness and expectation" and "Relationships between oneself and those around oneself". The total hope score varies between 0-90, and the total score for each sub-scale varies between 0-30. High scores obtained from the scale indicate a high level of hope. In the reliability study of the Turkish form of the scale, the Cronbach alpha coefficient was determined as 0.84.

Beck Depression Inventory II The Beck Depression Inventory was first developed by Aeoron T. Beck in 1961 to determine the risk of depression in individuals and to measure the level and severity of depressive symptoms. The validity and reliability of the BDI for the Turkish society was conducted by Çınarbaş et al. The BDI is a three-point Likert-type scale and consists of 21 items. A total score of 0-63 is obtained from the items, and an increase in the total score indicates an increase in depressive symptoms. The cut-off score for the Turkish society is generally accepted as 17.

Semi-structured qualitative interview form The semi-structured interview form to be used for the qualitative interview will be created by the researcher in line with expert opinion while preparing the psychoeducation program.

Data Collection There will be two groups selected by randomization in the study, experimental and control. The logotherapy-based program prepared in line with literature information and expert opinion will be applied to the family members in the experimental group using the focus group interview method.

YÖÖ, HUÖ and BDE will be applied to the family members at the beginning, end and follow-up of the psychoeducation program. In addition, qualitative data will be collected with the Semi-Structured Interview Form developed by the researcher during the follow-up phase.

Data Analysis The collected quantitative data will be brought together and coded. Then, the coded data will be transferred to the SPSS program database and the data will be separated into parametric and nonparametric groups and analyzed with hypothesis analysis.

Study Type

Interventional

Enrollment (Estimated)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Inclusion criteria

    • Volunteering to participate in the study
    • Having a family history of schizophrenia diagnosed according to DSM-5 diagnostic criteria
    • An individual diagnosed with schizophrenia being followed up with this diagnosis for at least one year
    • Being over the age of 18

Exclusion Criteria: Being treated or being treated for a mental disorder

  • Having received or being receiving psychotherapy Exclusion criteria from the study
  • Not attending at least two of the psychoeducation sessions
  • An individual diagnosed with schizophrenia being hospitalized

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Relatives of patients who underwent the application
Individuals in this group will receive 8 sessions of psychoeducation focused on logotherapy.
Other: logotherapy focused psychoeducation
8 sessions of online individual logotherapy focused psychoeducation program
No Intervention: relatives of patients in routine practice
Individuals in this arm will not be subjected to any additional intervention other than routine practices.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Finding meaning in life scale score
Time Frame: first week and eighth week
The meaning of life scale was developed by Steger and colleagues (1) to determine the meaning people find in life and the meaning they seek. The adaptation study for Turkey was conducted by Akın and Taş (2). The meaning of life scale consists of 10 items on a 7-point Likert type. The scale consists of two subscales, namely current meaning and sought meaning. The total score on the scale varies between 7 and 70. High scores obtained from the scale indicate that the individual has a high level of meaning in life. The internal consistency reliability coefficients of the scale are .82 for the current meaning subscale and .87 for the sought meaning subscale.
first week and eighth week
Herth Hope Scale Scores
Time Frame: first week and eighth week
The Herth Hope Scale (HUÖ) was developed by Dr. Herth in 1991 to determine the hope levels of individuals and was adapted to Turkish by Aslan and colleagues. The scale is a four-point Likert type and consists of 30 items. The scale consists of the sub-dimensions "Future", "Positive readiness and expectation" and "Relationships between oneself and those around oneself". The total hope score varies between 0-90, and the total score for each sub-scale varies between 0-30. High scores obtained from the scale indicate a high level of hope. In the reliability study of the Turkish form of the scale, the Cronbach alpha coefficient was determined as 0.84.
first week and eighth week
Beck Depression Inventory Scores
Time Frame: first week and eighth week
The Beck Depression Inventory was first developed by Aeoron T. Beck in 1961 to determine the risk of depression in individuals and to measure the level and severity of depressive symptoms. The validity and reliability of the BDI for the Turkish society was conducted by Çınarbaş et al. The BDI is a three-point Likert-type scale and consists of 21 items. A total score of 0-63 is obtained from the items, and an increase in the total score indicates an increase in depressive symptoms. The cut-off score for the Turkish society is generally accepted as 17.
first week and eighth week
Results of semi-structured qualitative form
Time Frame: tenth week
The semi-structured interview form to be used for the qualitative interview will be created by the researcher in line with expert opinion while preparing the psychoeducation program.
tenth week

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Personal İnformation Form
Time Frame: first week
This form, created by the researcher by scanning the relevant literature, consists of 14 questions aimed at determining the sociodemographic and disease-related characteristics of the individual diagnosed with schizophrenia and his/her family member.
first week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

aslı zeynep sipahi

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 3, 2025

Primary Completion (Estimated)

August 3, 2025

Study Completion (Estimated)

September 3, 2025

Study Registration Dates

First Submitted

December 30, 2024

First Submitted That Met QC Criteria

February 27, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 27, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 61351342Ekim/2022 21

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on logotherapy focused psychoeducation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe